Table 5.
Type of CD | [CUR] Formulation | Microorganism | Type of Culture | Antimicrobial Method | Antimicrobial [CUR] | Light/Ultrasonic Parameters | Reference |
---|---|---|---|---|---|---|---|
PEG-based β-CD or γ-CD | 10 µM | E. coli, E. faecalis | Planktonic | aPDT | 10 µM | 4.8, 29 J/cm2 | [133] |
HPMC-stabilized hydroxypro pyl-β-CD | 7.64 × 10−3 M | E. coli | Planktonic | aPDT | 10, 25 µM | 5, 14, 28 J/cm2 | [134] |
methyl-β-CD hyaluronic acid HPMC | 7.64 × 10−3 M | E. faecalis, E. coli | Planktonic | aPDT | 0.5–25 µM | 11, 16, 32 J/cm2 | [135] |
carboxymethyl-β-CD | 20 µM | E. coli | Planktonic | aPDT | 0.7 ± 0.1 to 4.1 ± 1.6 nmole cm−2 | 1050 ± 250 lx | [136] |
hydrogel with CUR in hydroxypropyl-β-CD | 15.8 mg/mL | S. aureus | Planktonic | Inhibition zone | 2% (w/v) | - | [137] |
α- and β-CD | 1 mol/L | E. coli, S. aureus | Planktonic | MIC, OD 600 nm | 0.25 and 0.31 mg/mL | - | [138] |
β-CD or γ-CD in CS | 0.06 mM | E. coli, S. aureus | Planktonic | MIC, Zone of inhibition | 64 and 32 µg/mL | - | [139] |
γ-CD | 25 mg/L | T. rubrum | Planktonic | MIC, aPDT | N/R | 45 J/cm2 | [140] |
hydroxypropyl-β-CD | 1:1 | B. subtillis, S. aureus, S. pyrogenes, P. aeruginosa, C. difficile, C. butyricum, L. monocytogenes, E. faecalis, E. coli, K. pneumoniae, P. mirabilis, S. typhimurium, E. aerogens, C. kusei, C. albicans | Planktonic | Inhibition zone | 25 mg/mL | - | [141] |
methyl-β-CD | 20 mM | E. coli | Planktonic | MIC, MBC, aPDT | 500, 90 µM | 9 J/cm2 | [142] |
[CUR]: CUR concentration. -: not performed. N/R: not reported.